A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure
Clinical trial NCT02157506 · COMPLETED
Trial details
- NCT number
- NCT02157506
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-30
- Primary completion
- 2015-05-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.